Navigation Links
Processed Tomato Products May Protect Against Inflammation, According to a Study Presented at the Experimental Biology Meeting
Date:4/21/2009

econd most popular vegetable in the country, represent an excellent opportunity to ward off chronic disease. Since processed tomato products are both economical and easily adaptable to a variety of cultural diets, their health benefits warrant further investigation.

Given the potential for tomato products to protect against chronic disease, researchers from the University of California, Davis, National Center for Food Safety & Technology in Illinois, and Penn State University investigated the effects of processed tomato products on vasodilatation (another target for lowering disease through dietary strategies) and C-reactive protein on overweight and obese men and women. Within the diets of 56 free-living individuals participating in the study, processed tomato products or non-tomato products were matched in calories, sodium, and sugar content. All of the test subjects consumed a low-tomato diet for three weeks followed by either a six week high-tomato diet or low-tomato diet. At six weeks, the subjects were assessed as to the response of tomato after eating a high-fat meal. Compared with the low-tomato group, the high-tomato group experienced a C-reactive protein level that was lower in response to the high-fat meal. High-tomato intake was also associated with increased mean vessel diameter, but flow mediated vasodilatation was not different, possibly related to the BMI of subjects. The researchers concluded that processed tomatoes provide a protective role on inflammation, but increasing adiposity may negate the benefits of the high-tomato diet on endothelial function.

Researchers in the study include Rose M Giordano, Tissa Kappagoda, Mandeep Cheema, Jack Cappozzo, Yumei Cao, Penny Kris-Etherton, and Britt Burton-Freeman. The study was sponsored by the Tomato Products Wellness Council (www.tomatowellness.com).

If you
'/>"/>

SOURCE Tomato Products Wellness Council
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MultiCell Technologies Signs Liver Stem Cell R&D Agreement To Develop Products for the Study of Liver Cancer
2. Evidence Lacking in Multivitamin Study of Womens Risk of Cancer, Heart Disease or Death, Says Natural Products Association
3. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)
4. Clinical Lab Products Magazine Features Biomoda
5. IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
6. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
7. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
8. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
9. Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
10. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
11. TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...rts 90 percent radiation reduction in cardiac CT s... -- Dr. James Earls, a radiologist from Fairfax Ra.... will present the findings of a study that shows ...heart patients received from CT scans compared to ...ill present the study to the annual meeting of the...
(Date:12/1/2009)...ERRY HILL, N.J., Dec. 1 ...urprised and delighted when his radiotherapy treat...20 minutes each day to less than five. Midway thr...ware Valley Urology Cancer Center acquired the r...ogy from Varian Medical Systems (NYSE: VAR ), m...
(Date:12/1/2009)...E, Tenn., Dec. 1 Cumberl...d today that an independently conducted study of A...ous N-acetylcysteine, as a cost-saving treatment f... 12, Number 4 of the peer-reviewed Journal of Med...udy concludes that Acetadote is a less costly trea...
Breaking Medicine Technology:Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 2Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 3Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 4Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 5Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems 6Nanoparticles used in common household items caused genetic damage in mice 10748 1Nanoparticles used in common household items caused genetic damage in mice 10748 2Nanoparticles used in common household items caused genetic damage in mice 10748 3Teen Girls at Higher Risk for STDs 3A Report 61460 1Teen Girls at Higher Risk for STDs 3A Report 61460 2Immunity to Swine Flu May Be Broader Than Thought 61457 1Immunity to Swine Flu May Be Broader Than Thought 61457 2Immunity to Swine Flu May Be Broader Than Thought 61457 3
...Congress of European Hematology,Association (EHA) ...tCall/ --,Immunomedics, Inc. , a biopharmaceutical...es to treat cancer and other serious,diseases, tod...ess,of EHA in Vienna, Austria, showed positive res...L) treated with a new,radioimmunotherapy (RAIT) us...
...ivational Reserve" May Also Affect,Alzheimer,s Ris...ire/ -- A new study,suggests that treating risk fa...lood pressure and diabetes, may slow the progressi...eported today at the,2nd Alzheimer,s Association I...in Washington, DC. , Two new studies presented at ...
Other Medicine Technology:Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 2Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 3Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 4Fractionated Radioimmunotherapy With (90)Y-epratuzumab in,Non-Hodgkin's Lymphoma Appears Safe and Active in a Phase I/II,Study 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 2Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 3Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 4Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 5Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 6Treating Heart Disease Risk Factors May Slow Alzheimer's Disease,Progression 7
(Date:12/1/2009)...-USNewswire/ -- The American Society of Hematology...on of blood specialists, expects more than 20,000 ...mber 5-8, 2009, at the Ernest N. Morial Convention...ase the latest research and treatments for blood d...51st annual meeting, where we will celebrate the s...
(Date:12/1/2009)...ire/ -- A national survey reveals the majority of ...es and themselves but at the same time want the ri...amilies. ,, See video from HealthyWomen at: ht... of mothers of children aged 12 months and younger...eeding decision prior to going to the hospital to ...
(Date:12/1/2009)...ire/ -- Edifecs, Inc., the proven leader in HIPAA ...s announced an enhanced release of Edifecs XEngine... 5010 migrations. XEngine Translator provides out-...eration of test data and permits two-way translati...ressing most requirements for organizations planni...
(Date:12/1/2009)...creening test, expert says , , TUESDAY, ... lead to a simple blood test to screen for lung ca...em markers that indicate early-stage lung tumors i...searchers examined gene expression profiles in blo...ng cancer and a control group of 91 people with no...
(Date:12/1/2009)...ver surgery after chemo, study finds, , ...f liver tumors caused by the spread of colorectal ...motherapy, researchers report. , Adding bevaciz...shown to improve survival in patients with late-st...s in patients having surgery to remove colorectal ...
Breaking Medicine News(10 mins):Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 2Health News:Edifecs Delivers Enhanced HIPAA 4010A1 to 5010 Migration Capabilities for Healthcare Organizations 3Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:CT Scan May Predict Colon Cancer Survival 2
...ted to attend a congressional breakfast briefing o...mber 25, 2008. This event will serve as the closin... The Gerontological Society of America (GSA). , P... work quickly with congressional leaders to enact ...
...ov. 19 Mangos, a full-service advertising,agency,...m Medical Marketing &,Media (MM&M), a lead...nizes,exceptional creativity and effectiveness in ...oto: http://www.newscom.com/cgi-bin/prnh/2008111...
.... 19 Scott P. Serota, President and Chief Executi...iation (BCBSA), released the following statement: ...eld companies have been steadfast champions of com...ed that policymakers on both sides of the aisle ar...
... Nov. 19 Arabesque, an imprint of Kimani Press of...t. Jude Children,s Research Hospital(R) in conjunc...p; Hope. The donation was presented recently at a ...andra Kitt and Gwynne Forster attended to autograp...
... Nov. 19 Eli Lilly and Company recently,unveiled ... America,s Guide to,Healthy Living, with useful ti...life and prevent chronic diseases such as heart di... healthy life. , "A Healthy You! -- America,...
...alif., Nov. 19 Consumer Watchdog said the health ...lth care reform on the condition that it includes ...verage - the so called "individual mandate" - is s...s health care problems and will only encourage the...
Other Medicine News:Health News:Mangos Wins Two Gold Awards 2Health News:BCBSA Announces Support for Individual Mandate Coupled With a Requirement for Insurers to Offer Coverage to All 2Health News:Arabesque Books Donates $15,000 in Support of St. Jude in Conjunction With a New Fall Book Series 2Health News:Lilly Offers Free Health Guide, Available throughout State 2Health News:Consumer Watchdog Comments on Health Insurer's Self-Serving Support of 'Individual Mandate' 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: